RESEARCH GRANT ADVISORY BOARD

adamson-peter_edited.jpg

More...

Prior Chair of the Children’s Oncology Group (COG)

Dr. Peter Adamson

Langena-scholars-headshot.jpg

More...

Associate Professor of Pathology, Harvard Medical School, Director of the Molecular Pathology Unit, Massachusetts General Hospital

David Langenau PhD

1531322451939_edited.jpg

More...

 St Jude Children’s Hospital

Dr. Elizabeth Stewart

wexler_170207_09_3x2_edited.jpg

More...

Memorial Sloan Kettering Cancer Center

Dr. Lenny Wexler

douglas-hawkins.jpg

More...

Hematology/Oncology Division Chief, Associate Director of the Center for Clinical and Translational Research at Seattle Children’s Hospita

Dr. Doug Hawkins

corinne-m-linardic-md-phd_edited.jpg

More...

Pediatric Hematology Oncologist Duke University Hospital, Associate Professor of Pharmacology and Cancer Biology, Member of the Duke Cancer Institute

Dr. Corinne Linardic

Chris-Vakoc-2L6A0172_1_1.jpg

More...

At Cold Spring Harbor coming from University of Pennsylvania

Chris Vakoc MD, PhD

CHLA-Lee-Helman-255.jpg

More...

Section Head, Basic and Translational Research within the Children’s Center for Cancer and Blood Disease. Director, Cancer and Blood Disease Research Program at The Saban Research Institute of Children’s Hospital Los Angeles. 

Dr. Lee Helman

DR. PETER ADAMSON

Chair of the Children’s Oncology Group (COG), a group of more than 200 leading children hospitals and cancer centers that bring together more than 9,000 international experts in childhood cancer. A reviewer for Blood, Cancer, Cancer Chemotherapy and Pharmacology, cancer Research, Clinical Cancer Research, Journal of Clinical Oncology, Journal of Pediatric hematology /Oncology, Journal of the National Cancer Institute, Leukemia, Leukemia Research

  • White LinkedIn Icon
  • White Twitter Icon
  • White Google+ Icon
In-2C-34px-R.png
DAVID LANGENAU PHD

Associate Professor of Pathology, Harvard Medical School, Director of the Molecular Pathology Unit, Massachusetts General Hospital. His laboratory focus is to uncover relapse mechanisms in pediatric cancer, utilizing the zebra fish model

  • White LinkedIn Icon
  • White Twitter Icon
  • White Google+ Icon
In-2C-34px-R.png
DR CORINNE LINARDIC

Pediatric Hematology Oncologist Duke University Hospital, Associate Professor of Pharmacology and Cancer Biology, Member of the Duke Cancer Institute. Has received a multitude of grants and awards in pediatric cancers and rhabdomyosarcoma.

  • White LinkedIn Icon
  • White Twitter Icon
  • White Google+ Icon
In-2C-34px-R.png
DR ELIZABETH STEWARD

spotlight video

St Jude Children’s Hospital. Has published numerous articles in pediatric soft tissue sarcomas with research interests in high risk pediatric solid tumors, tumor xenografts, and translational pre-clinical testing. She has also received several investigator awards.

  • White LinkedIn Icon
  • White Twitter Icon
  • White Google+ Icon
In-2C-34px-R.png
CHRIS VAKOC MD, PHD.

From the University of Pennsylvania. He runs the Vakoc Laboratory at Cold Spring Harbor Research Institute. He focuses on Cancer Epigenetics Research studying gene expression control. He is the recipient of multiple awards that include AACR Outstanding Achievement in Cancer Research, Forbeck Scholar Award, Leukemia and Lymphoma Society Award, Pershing Square Sohn Prize, and others, and has numerous publications.

  • White LinkedIn Icon
  • White Twitter Icon
  • White Google+ Icon
In-2C-34px-R.png
DR LENNY WEXLER

Memorial Sloan Kettering Cancer Center. He served on the faculty of the Pediatric Branch at The National Cancer Institute where he was involved in numerous clinical trials involving soft tissue sarcomas. He co-chaired the pilot study p9754 involving the role of therapy in osteogenic sarcoma. He is the Principal Investigator of MSKCC IRB pilot clinical trial for patients with newly diagnosed, intermediate, and high-risk rhabdomyosarcoma. He is also collaborating with other MSKCC physicians to develop biologically targeted novel therapies for children with recurrent rhabdo. He is the author of over 40 articles on the care of patients with pediatric sarcomas.

  • White LinkedIn Icon
  • White Twitter Icon
  • White Google+ Icon
In-2C-34px-R.png
DR LEE HELMAN

Section Head, Basic and Translational Research within the Children’s Center for Cancer and Blood Disease. Director, Cancer and Blood Disease Research Program at The Saban Research Institute of Children’s Hospital Los Angeles. He served as Head of Pediatric Oncology Branch at NCI and Scientific Director for Clinical Research National Cancer Institute 1997-2017. He is the past member of the Board of Governors of the Clinical Center at NIH. He serves on a multitude of Scientific Advisory Boards. Dr. Helman’s Lab currently studies the biology and treatment of rhabdomyosarcoma, Ewing’s sarcoma, osteosarcoma, and GIST tumors. 

  • White LinkedIn Icon
  • White Twitter Icon
  • White Google+ Icon
In-2C-34px-R.png
DR. DOUG HAWKINS

Hematology/Oncology Division Chief, Associate Director of the Center for Clinical and Translational Research at Seattle Children’s Hospital. He is a leader of the COG and the Chair of the Soft Tissue Sarcoma Committee which oversees the conduct of biology studies and clinical trials for rhabdomyosarcoma and other soft tissue sarcomas. He has been the chair of two COG trials.

  • White LinkedIn Icon
  • White Twitter Icon
  • White Google+ Icon
In-2C-34px-R.png